(1)
Muraleedharan, T.; Ammineni, K.; Shah, P.; Srijamya. Residual Inflammatory Risk in Atherosclerotic Cardiovascular Disease: Is Anti-Inflammatory Therapy the Next Frontier Beyond LDL Reduction?. Int J Med Stud 2026.